Healthy and high quality of life has become the main issue with increasing human life span. Many biological treatments for osteoarthritis of the knee have been tried with limited success. We compared data from 7 patients who underwent total knee arthroplasty and 46 patients who underwent autologous bone-marrow mesenchymal cell induced chondrogenesis (MCIC) for osteoarthritis of grade IV of the Kellgren-Lawrence classification and grade IV of modified Outerbridge classification from 50 to 65 years of age. Clinical evaluation of the 2 groups showed significant improvement in the mean telephone Knee Society Scoring system (tKSS)-A (pain) and tKSS-B (function) scores throughout the postoperative follow-up period. There was no difference in the patients' satisfaction between the 2 groups. MCIC is a treatment option at least for delaying disease progression of osteoarthritis of the knee. Tissue Eng Regen Med 2016;13(2): [200][201][202][203][204][205][206][207][208][209] 
INTRODUCTION
Total knee arthroplasty (TKA) is an important option to relieve pain and restore the function of advanced osteoarthritis of the knee. The procedure has a high success rate and the device lasts well over a decade [1, 2] . However, as the human life span is extended, revisional surgery rate is also increasing [3] . Despite the high success rate of TKA, complications such as infection, deep vein thrombosis, and implant related problems are critical issues. Furthermore, TKA is a very painful procedure and revisional surgery is even more painful [4] [5] [6] .
Hence, many patients are reluctant to have this surgery and try to find other options that preserve the knee joint instead of replacement [7] . People want to live without medical illness, free from osteoarthritis. Delaying the development of osteoarthritis is thus important [8] .
Many biologic treatments for cartilage defects reportedly have good results. One-stage cartilage regeneration procedures (CRPs) were introduced as a potential cell therapy [9, 10] . Autologous bone-marrow mesenchymal cell induced chondrogenesis (MCIC) is one such CRP that is a single staged, arthroscopic surgery [11] . This technique uses microfracture, bone marrow aspiration concentrate (BMAC), hyaluronic acid (HA) and fibrin gel to treat articular cartilage defects. Recently, simple comparison of TKA and MCIC regardless of age showed significant clinical improvement [12] .
However, one of the important goals of CRPs is delaying TKA and the targeted group is around 60 years of age. We evaluated advanced osteoarthritis patients aged between 50 to 65 years who were treated with MCIC. The data of TKA patients of the same age and same stage of osteoarthritis were used as reference.
MATERIALS AND METHODS

Patients
Data from 7 patients aged between 50 to 65 years who underwent TKA and 46 patients who underwent MCIC of the same age group for the treatment of Kellgren-Lawrence grade IV and modified Outerbridge grade IV osteoarthritis between June 2010 and June 2015, at a single center were included. Among the 46 MCIC patients, there were 13 males (28.3%), and 33 females (71.3%); and bilateral MCIC patients were 8 (17.4 %). The mean age of TKA patients was 60 years (SD=1.7) and that of MCIC was 56.8 years (SD=3.5). The average follow-up period was divided by 24 months, that is less than 24 months and less than 24 months (Table 1) .
There was no additional surgery including TKA or high tibial osteotomy, during the follow up period. The study was approved by the Institutional Review Board (The Catholic University of Korea).
Evaluation of patient suitability for study participation (inclusion and exclusion criteria)
All included patients were between 50 to 65 years of age and showed grade IV of Kellgren-Lawrence classification in the radiographs of weight bearing standing anteroposterior (AP), and 45 degree flexion posteroanterior (PA) and grade IV of modified Outerbridge classification arthroscopically (Fig. 1) . The knee joint was required to be stable and without a severe deformity of >10 degrees of the valgus or varus, in the mechanical femorotibial angle of both lower extremities on standing AP radiographs.
All included patients had no clinical improvement in response to at least 6 months of prior conservative treatments (including medication, intraarticular injection, and physical therapy).
All operations were performed by a single surgeon. The exclusion criteria included early osteoarthritis (KellgrenLawrence Grading Scale≤3) and inflammatory arthritis with severe deformity, exceeding the above mentioned range, patellofemoral instability, >10 degree of flexion contracture, drug abuse history, and psychological problems.
Surgical technique
Cartilage regeneration
Harvesting of bone marrow
After suitable anesthesia, the patient's anterior superior iliac spine was marked, cleaned and draped. Bone marrow aspiration needle (SPASY TM , CYP Biotech, Seoul, Korea) and syringes preloaded with 4 mL Anticoagulant Citrate Dextrose solution (Huons ACD Injection, Huons, Seongnam, Korea) were used to aspirate 38 mL of bone-marrow from the iliac crest. The aspiration site was injected with local anesthetic and covered with a sterile plaster. The bone marrow aspirate was centrifuged twice (BMC kit TM , Revmed & CYP biotech, Seoul, Korea). The first cycle was for 6 minutes at 2700 g, followed by a second cycle for 5 minutes at 2400 g, to obtain bone marrow aspirate concentrate (BMAC).
Preparation of BMAC, HA and fibrin gel mixture For application to the chondral defect, two 1 mL syringes are connected to a Y-shaped mixing catheter. One syringe contained 0.8 mL of fibrinogen (GreenPlast TM , Greencross, Seoul, Korea) and 0.2 mL of HA (Highhyalplus, Huons, Seongnam, Korea). The second syringe contained 0.8 mL of bone marrow concentrate and 0.2 mL of thrombin (Greenplast TM , Greencross, Seoul, Korea).
Arthroscopic procedures of arthritis
The knee was approached via antero-lateral and antero-medial arthroscopic portals and normal saline was infused under pressure (approximate to systolic blood pressure). A Wolf cannula (Karl Storz GmbH, Tuttlingen, Germany) was inserted superolaterally as an outflow cannula. The knee joint was system- Fig. 2A and B) .
Application of BMAC, HA and fibrin gel mixture Saline was drained from the knee joint and carbon dioxide (CO2) was introduced at 20 mm Hg, at a rate of 20 L/min using the Wolf cannula (Karl Storz GmbH) and disposable tubing with a filter (Insufflation tubing with Wolf adaptor, Leonhard Lang UK Ltd., Stroud, UK) through the supero-lateral portal. Residual saline was aspirated from the knee by a 20 mL syringe and an angled suction tube under low pressure to avoid bleeding. The microfractured lesion(s) was dried with cotton buds. A 18 gauge spinal needle (inner diameter 1.2 mm, length 90 mm) (Becton Dickinson, Madrid, Spain) was inserted into the joint via any suitable portal and was connected to the double syringe. Under arthroscopic guidance, the BMAC, HA and fibrin gel mixture was gently applied, via the double syringe, uniformly over the lesion. For patello-femoral joint lesions, a patellar clamp (Lewin bone clamp) was used to lift and stabilize the patella. Due to the tamponade effect of the CO2 and the adhesiveness of the gel, the graft adheres to the lesion, even against gravity. If necessary, a second layer was injected deep into the firm first layer (Fig. 2C) . The graft could be shaped in situ using a McDonalds dissector (Bolton Surgical, Sheffield, UK). The graft became firm after 5 minutes and under arthroscopic vision, the knee was then moved through its range of motion several times to anatomically sculpt the graft and test its stability (Fig. 2D ). If satisfactory, the CO2 was switched off and all instruments were withdrawn. The portal sites were injected with local anesthetic (0.5% Chirocaine) and closed with sutures. The knee was covered with a compression bandage. Bone marrow aspirates were diluted 1:1 with PBS (Gibco Invitrogen, Grand Island, NY, USA) and carefully loaded onto Histopaque (1.077g/mL) (Sigma Chemical Co., St. Louis, MO, USA) to isolate bone marrow mononuclear cells (MNCs). MNCs were isolated by density gradient centrifugation (400 g, 25 min, room temperature) and washed three times with a-MEM (Gibco Invitrogen, Grand Island, NY, USA). The final resuspension was done after filtration through a 70 um cell strainer (Becton Dickinson/Falcon, Heidelberg, Germany).
2) Automatic cell count
The number of nucleated cells, lymphocytes, monocytes, red blood cells, platelet and neutrophil granulocytes were counted before MNC of bone marrow aspirate and BMAC isolation using a cell counter (XE2100, Cysmax, Japan). The number of MNC was calculated by summing the lymphocytes and monocytes (Supplementary Table 1 in the online-only Data Supplement).
3) CFU-F assay
A colony forming units-fibroblast assay was performed to quantify non-hematopoietic fibroblastic colonies. Isolated mononucleated cells were cultured in 10 mm diameter cell culture dishes (Becton Dickinson/Falcon, Heidelberg, Germany) for 14 days at 37°C in humidified atmosphere and 5% CO2. The medium using a-MEM (Gibco, Life Technologies, Karlsruhe, Germany) with 20% FBS (Gibco, Life Technologies, Karlsruhe, Germany), penicillin (100 U/mL; Gibco, Life Technologies, Karlsruhe, Germany) and streptomycin (100 ug/mL; Gibco, Life Technologies, Karlsruhe, Germany).
After 14 days, adherent cells were fixed with paraformaldehyde (Biosesang, Seongnam, Korea) for 5 min washed, and stained with 1% crystal violet. Colonies were counted macroscopically and visual inspection with the plate on a white piece of paper ( Supplementary Fig. 1 in the online-only Data Supplement). Immunophenotyping of BM and BMAC was performed by flow cytometry using a FACS Calibur cytometer (BD Biosciences, Heidelberg, Germany). PE-labeled antibody (Ab): CD44, CD13, CE29, CD19, CD11 APC-labeled Ab: CD90, CD105, FITC-labeled Ab: CD34 ( Supplementary Fig. 2 in the onlineonly Data Supplement).
Total knee joint replacement arthroplasty
TKA was performed through the midline skin incision and medial parapatellar approach. The implants were of the posterior stabilized type (Lospa, Corentech, Seoul, Korea) and femoral and tibial components were fixated by cement. Patella was not replaced.
Rehabilitation
Continuous passive motion (CPM) machines were used for rehabilitation from the day 1 post-surgery, in both groups.
Quadriceps muscle strengthening exercise was continued during the pre and post operation period. For TKA patients, partial weight bearing walking exercise with crutch or walker was started from the 2nd day post-surgery, and followed by full weight bearing, according to the patient comfort. For MCIC patients, partial weight bearing walking exercise with a crutch or walker was started from the 2nd day post-surgery, and followed by full weight bearing, beginning 6-8 weeks post-operatively. The weight bearing was protective of the operation site, and excessive weight to the lesion was prevented, to assist in cartilage regeneration. CPM was used for 30 minutes on the 1st day and daily increments of 10 minutes up to a total of 4 hours per day.
Patient evaluations
Details concerning the patients' clinical outcomes were collected using the telephone score format initially used to estimate the KSS ( Supplementary Fig. 3 in the online-only Data Supplement) [13] . The above information was obtained pre-operative- Our clinicians rated the patient knee status using the standardized 100-point rating scale of the telephone Knee Society Scoring system (tKSS) regarding pain (A) and function (B). Data on adverse events regardless of relatedness to surgery were collected and included in the analysis.
Statistical analysis
Categorical variables were presented as numbers and percentages, and continuous variables were expressed as mean±SD and range. Categorical variables were analyzed using the Fisher exact test. The nonparametric Wilcoxon signed rank test was used for the comparison of means between the 2 groups based on the result of test for normality. The Mann-Whitney U test was used for the general mean comparison between the 2 groups. For parametric test, the mean comparison between 2 groups was by independent t-test. Categorical variables after Dummy parameterization were analyzed using the Enter method multiple regression analysis, two-way ANOVA to determine the pattern and relative influence among the variables. SPSS software version 14.0 (SPSS Inc, Chicago, IL, USA) was used for statistical analyses.
RESULTS
Patients
The number of MCIC patients was 46 with the mean age of 56.8 years (SD=3.5). The number of TKA patients was 7 with the mean age of 60 years (SD=1.7). The age difference in the two groups showed a statistical significance, where TKA patients were older than MCIC patients (p=0.01).
The age variable was divided into 2 groups: there were more patients less than 60 years old in MCIC and more patients older than 60 years old in TKA.
The difference in the follow-up period between the two group showed a statistical significance (p<0.01) and the average followup period was divided by 24 months. MCIC had a longer follow-up period of average 28 months, while the 84.8% patients had the follow-up period over 24 months.
Females were predominant and there was no statistically significant difference between the 2 groups in the patients' satisfaction, sex, lesion side (Table 1) .
Clinical outcome
Clinical evaluations in the 2 groups showed significant improvement in the mean tKSS-A (pain) and tKSS-B (function) scores for all post-operative data throughout the follow-up period (Table 2) .
There was no statistically significant difference in the degree of improvement between the 2 groups (Table 3 ). In the analysis of the relative influence of patient characteristics and treatments on the improvement of pain, function, and satisfaction, only age variable showed a contrary relationship (p=0.03). The young age showed better pain improvement and other variables such as sex, side of lesion, and treatment method showed no effect on the pain, function, and satisfaction ( Table 4) .
The age variable was divided into 2 groups. The improvement of pain showed a statistically significant difference in age groups (p=0.03). Patients younger than 60 years of age showed a better improvement in pain relief compared to those older than 60 years of age, with no statistically significant difference between the 2 treatment methods ( Table 5) .
The pain and functional improvements of each treatment method according to the follow-up period were not significantly different, but TKA showed a tendency of improved pain when compared to MCIC, according to the follow-up period.
MCIC showed a tendency of improved function when compared to TKA, but TKA showed a marked improvement in function after 2 years of follow-up period (Table 6 and 7) .
Adverse events
There was no adverse event.
DISCUSSION
TKA has been the mainstream treatment for osteoarthritis of the knee for the past several decades and will be the gold standard of treatment for severe and deformed arthritis in the fu- [14] . Long-term follow up of TKA provides relief to the patients and helps to expand the indication of TKA to the younger patients [15] . Despite these successful results, complications after TKA are very critical issues [16] [17] [18] . Infection, deep vein thrombosis, pulmonary embolism, surgical-procedure related problems such as malalignment and gap imbalance are debilitating. These complications require specific treatments ranging from medication to re-operation. The pain after surgery is very severe and has been addressed by several research studies [19, 20] . Many successful results of TKA are reported. However, since the concerns and priorities of patients differ from those of surgeons it is difficult to evaluate the success of TKA due to subjective nature of satisfaction [21] . Since many patients suffer from continuous pain after TKA, and the revisional surgery findings often reveal abnormal tissue formation, osteolysis, various inflammations, we accordingly try to find an alternative treatment for osteoarthritis [7] . Even though TKA longevity is extended, the chance of revisional TKA has increased with increased life span. There are high risk complications related to the revisional TKA, and operations are very painful [22] . Many patients are reluctant to receive TKA due to these complications, and thus, both patients and surgeons prefer alternative treatments that can preserve the knee joint instead of replacement.
Therefore, biological treatments such as stem cell treatments, cultured cell therapy, and bone marrow cell concentrations have become popular currently. Cultured cell therapies like autologous chondrocyte implantation (ACI) or matrix induced ACI are good treatment options for articular cartilage defects [23] . However, they require 2 surgeries, i.e., tissue harvest operation followed by cell culture and implantation operation. The recovery is often prolonged and expensive due to the cell culture process and 2 operations. Also, there are few reports regarding the treatment of arthritis using ACI [24] .
Ease and effectiveness by single-stage minimal invasive treatments are necessary for patient satisfaction. Cartilage regeneration operations based on the arthroscopic marrow stimulation procedure such as microfracture or multiple drilling were introduced and short-term results were reported.
Microfracture is a technique that covers injured articular cartilage through the proliferation and differentiation of bone marrow derived mesenchymal cells [25] . Microfracture is simple, minimally invasive using arthroscopy, and a cost effective firstline treatment option for focal cartilage defects [26] . The theoretical basis of this procedure is that the hematoma from the penetrated bone marrow contains marrow stromal cells including mesenchymal stem cells that differentiate into chondrocytes and synthesize cartilage.
This study extended this single stage minimally invasive surgery for focal cartilage defect to osteoarthritis treatment. A mixture of concentrated bone marrow cells, HA and fibrin were used for cartilage regeneration after arthroscopic microfracture.
Firstly, routine arthroscopic surgery including the removal of osteophyte, synovectomy, debridement, microdrilling and microfracture of arthritic surface of cartilage, was conducted ( Fig.  2A and B) . Under continuous CO2 inflation, a mixture of concentrated bone marrow cells, HA and fibrin without another skin incision was injected through arthroscopic portals to the (Fig. 2C) . Continuous CO2 inflation is the key to this technique. Clinically, CO2 gas is safely used in laparoscopic surgery, where intraarticular positive pressure of CO2 gas facilitates the attachment of the injected mixture to the articular surface. After the attachment of the mixture to the surface, the fibrin in the mixture leads to consolidation via the action of fibrinogen and thrombin, and then BMAC can be attached in the defect area (Fig. 2D) .
A new articular surface could be formed through controlling the speed, direction, and location of injection. With this technique, all knee cartilages including the cartilage of patella and posterior femoral condyle are accessed without a skin incision.
Microfracture is a simple, easy and effective procedure for small lesions of articular cartilage. For large lesions, newly formed cartilage after microfracture is scanty and brittle. The injected concentrated bone marrow cells could participate in articular cartilage regeneration to overcome this limitation of microfracture alone. Also, HA of a mixture improves repair potential, leading to a more hyaline-like repair tissue, with better defect fill and adjacent area integration (Fig. 4) [27] . The newly introduced operation technique using continuous CO2 inflation and the injection of the mixture into the cartilage lesion leads to rapid recovery.
In this study, the patients who received MCIC could be TKA candidates because they had advanced osteoarthritis of knee. However, they chose the CRP instead of TKA after receiving an explanation of the surgical procedure. Despite possibilities of the failure of MCIC for the treatment of osteoarthritis, as compared to focal cartilage defect, patients preferred avoiding TKA and delayed replacement operation.
Patients were carefully selected to increase the possibility of procedural success. The candidates did not have severe valgus or varus deformity that needed corrective osteotomy (Fig. 3) , had enough spare time for rehabilitation, and were willing to follow surgeon's instructions. The previously defined optimal age for TKA was older than 60 years [28] . However, if the increased life span is considered, the optimal age of TKA should be older than 70 years. Therefore, the age groups who can have benefits of evading or delaying TKA range between 50 to 60 years old. In this study, the evaluated age group of 50 to 65 years old showed results comparable to TKA. If TKA is delayed or avoided, the socioeconomical benefits are significant [29] .
The weak point of this study was the small number of patients that made it difficult to conclude that MCIC was a good treatment option for osteoarthritis. However, MCIC was possibly an effective replacement of TKA for the treatment of osteoarthritis without severe deformity. This study will facilitate further development of CRPs to substitute total joint replacement operation.
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